JAK2 and essential thrombocythemia: Patients with PV tend to have higher allelic burden of the JAK2 mutation in comparison to patients with ET, with about 25 to 30% of PV and 2 to 4% of ET harboring a homozygous JAK2 mutation, usually due to uniparental disomy.